Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 139 Posts
1 2 3 ... 9
Top Five Weekend Stock Stories - May 19, 2019
Article By: The Fly Sunday, May 19, 2019 8:37 PM EDT
Catch up on the weekend's top five stories with this list compiled by The Fly...
In this article: BWA, DIS, JWN, MCD, SCHW, TSN, REGN, AMAT, GOOG, TTWO, GOOGL, TPR, LGF-A
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read
Leaders Reporting Tomorrow
Article By: Bespoke Investment Group Tuesday, February 5, 2019 5:35 PM EDT
Among the companies set to report earnings on Wednesday are Regeneron Pharmaceuticals, Chipotle, and Spire.
In this article: REGN, CMG, SR
Read
13 Monster Stock Market Predictions For The Week Of January 28
Article By: Michael J. Kramer Sunday, January 27, 2019 12:46 PM EDT
The week of January 28 will definitely not be a dull one with a monster week for earnings from tech titans and more.
In this article: NKE, ACAD, REGN, GILD, MU, NFLX, GOOGL, SQ, ROKU, BB, BABA, JD
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research Wednesday, January 23, 2019 2:06 PM EDT
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Sunday, October 28, 2018 2:00 PM EDT
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly Saturday, August 11, 2018 9:37 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
Stocks For You To Swing-Trade: REGN, CMA, SCHW
Article By: Ryan Mallory Friday, August 3, 2018 6:04 AM EDT
Take a look at three trading ideas to prep you for the next trading session.
In this article: CMA, SCHW, REGN
Read
Q2 Earnings Update: Bluebird Bio (BLUE) And Regeneron (REGN)
Article By: Rod Raynovich Thursday, August 2, 2018 11:09 PM EDT
Regeneron Pharmaceuticals (REGN) soared 7% to $397 on earnings beat with adjusted EPS of $5.45. Bluebird Bio (BLUE) was up 0.79% to $156.60 despite losses and lagging revenue.
In this article: BLUE, REGN
Read
Biotechnology Stocks Preparing A New Bullish Trend
Article By: Taki Tsaklanos Sunday, July 8, 2018 11:26 AM EDT
Biotechnology stocks look bullish, and even more bullish than ever in the last three years.
In this article: IBB, ILMN, REGN, BIIB, CELG, XBI, ARRY, FOLD, SGMO, XLRN
Read
Regeneron (REGN) Beats On Q1 Earnings
Article By: Zacks Investment Research Thursday, May 3, 2018 10:07 AM EDT
Regeneron’s first-quarter 2018 earnings topped expectations. Our consensus called for EPS of $4.51 and the company reported EPS of $4.67.
In this article: REGN
Read
Regeneron Pharmaceuticals: Sequencing Its Way To +30% Upside
Article By: Matthew Hogan Thursday, May 3, 2018 6:05 AM EDT
Regeneron's stock price fall over the last 10 months is not supported by the numbers. With a broadening portfolio of drugs on the market, the company is set to prove to investors that it is not a one-trick pony.
In this article: REGN Also: AET, CCE, CI, CVS, AVGO, CELG, ESRX, VRTX, YY, CC
Read
Morning Call For Monday, April 9
Article By: Jim Van Meerten Monday, April 9, 2018 10:54 AM EDT
Chicago Fed President Evans said the Fed should continue gradually raising interest rates if data on consumer prices indicate inflation will soon reach its 2% target. Stocks are up as global markets rally on reduced US-China trade concerns.
In this article: DFS, GM, SYNA, KOOL, OLED, QCOM, SWKS, QRVO, BA, BEN, REGN, IAC, A, AMTD
Read
Bull Of The Day: Regeneron
Article By: Kevin Cook Wednesday, March 14, 2018 10:53 AM EDT
Regeneron Pharmaceuticals shares have been on an odyssey in the past year, soaring from $360 last April up to $540 by June and then entering their own private bear market since last autumn to dip below $320 this year.
In this article: REGN Also: SNY, AMGN, BIIB, GILD
Read
3 Biotech Stocks With Rising Earnings Estimates Post Q4
Article By: Zacks Investment Research Tuesday, March 13, 2018 4:17 PM EDT
The Q4 earnings season for the pharma/biotech sector was scattered with a few small biotech companies yet to report. The releases so far provide us with a clear picture of the sector’s performance.
In this article: LGND, REGN, HZNP Also: SNY, AMGN, BIIB, CELG, GILD, VRTX
Read
1 to 16 of 139 Posts
1 2 3 ... 9